Randomized Controlled Trial to Compare the Safety and Efficacy of Tamsulosin, Solifenacin, and Combination of Both in Treatment of Double-J Stent-Related Lower Urinary Symptoms
Table 2
Comparisons of IPSS/QoL, VAP scale, and OAB-q scores in all groups.
Group I
Group II
Group III
Group IV
value
C group
T group
S group
T/S group
IPSS (storage symptom score)
Preinsertion
0.989
2 weeks after insertion
0.000
IPSS (voiding symptom score)
Preinsertion
0.988
2 weeks after insertion
0.000
IPSS (total score)
Preinsertion
0.986
2 weeks after insertion
0.000
Qol score
Preinsertion
0.862
2 weeks after insertion
0.000
OAB-q score
Preinsertion
0.255
2 weeks after insertion
0.000
VAPS score
Preinsertion
0.172
2 weeks after insertion
0.000
IPSS: International Prostate Symptom Score; QoL: quality of life; OAB-q: Overactive Bladder Questionnaire; VAPS: Visual Analogue Pain Scale.